Literature DB >> 19943320

Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase.

Khalid Matrougui1.   

Abstract

Type 2 diabetes is responsible for the increased prevalence of ischaemic heart disease, generally related to coronary artery disease, which is associated with increased morbidity and death in diabetic patients. Epidermal growth factor receptor (EGFR) tyrosine kinase, one of the many factors involved in cell growth and migration, has been shown to be key element in the development of microvessel myogenic tone. In a recent study, we have shown that microvascular dysfunction in type 2 diabetes is dependent on the exacerbation of the EGFR tyrosine kinase phosphorylation. Thus, further elucidation of this EGFR transactivation and down stream signalling will offer a new direction to investigate the mechanism of microvascular dysfunction responsible for heart disease that occurs in type 2 diabetes. In this review, we discuss the link between the EGFR transactivation and microvascular dysfunction that occurs in type 2 diabetes. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19943320      PMCID: PMC2823570          DOI: 10.1002/dmrr.1050

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  18 in total

1.  Cross-sectional area and volume compliance of porcine left coronary arteries.

Authors:  G S Kassab; S Molloi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-08       Impact factor: 4.733

2.  Increased myogenic tone in skeletal muscle arterioles of diabetic rats. Possible role of increased activity of smooth muscle Ca2+ channels and protein kinase C.

Authors:  Z Ungvari; P Pacher; V Kecskemeti; G Papp; L Szollár; A Koller
Journal:  Cardiovasc Res       Date:  1999-09       Impact factor: 10.787

3.  Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries.

Authors:  G J Lagaud; E Masih-Khan; S Kai; C van Breemen; G P Dubé
Journal:  J Vasc Res       Date:  2001 Nov-Dec       Impact factor: 1.934

4.  An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.

Authors:  Peiyong Zhai; Jonathan Galeotti; Jing Liu; Eric Holle; Xianzhong Yu; Thomas Wagner; Junichi Sadoshima
Journal:  Circ Res       Date:  2006-08-10       Impact factor: 17.367

5.  Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.

Authors:  N J Morrish; S L Wang; L K Stevens; J H Fuller; H Keen
Journal:  Diabetologia       Date:  2001-09       Impact factor: 10.122

6.  Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature.

Authors:  Ibrahim F Benter; Mustapha Benboubetra; Andrew J Hollins; Mariam H M Yousif; Halit Canatan; Saghir Akhtar
Journal:  Vascul Pharmacol       Date:  2009-07-02       Impact factor: 5.773

7.  Amplification of coronary arteriogenic capacity of multipotent stromal cells by epidermal growth factor.

Authors:  Souad Belmadani; Khalid Matrougui; Chris Kolz; Yuh Fen Pung; Desiree Palen; Darwin J Prockop; William M Chilian
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04-02       Impact factor: 8.311

8.  Role of elevated EGFR phosphorylation in the induction of structural remodelling and altered mechanical properties of resistance artery from type 2 diabetic mice.

Authors:  Desiree I Palen; Khalid Matrougui
Journal:  Diabetes Metab Res Rev       Date:  2008 Nov-Dec       Impact factor: 4.876

Review 9.  The epidermal growth factor receptor ligands at a glance.

Authors:  Marlon R Schneider; Eckhard Wolf
Journal:  J Cell Physiol       Date:  2009-03       Impact factor: 6.384

10.  Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells.

Authors:  Dai Shida; Joji Kitayama; Ken Mori; Toshiaki Watanabe; Hirokazu Nagawa
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

View more
  18 in total

Review 1.  Quantification of myocardial blood flow and flow reserve: Technical aspects.

Authors:  Ran Klein; Rob S B Beanlands; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

2.  Metabolic syndrome impairs reactivity and wall mechanics of cerebral resistance arteries in obese Zucker rats.

Authors:  Steven D Brooks; Evan DeVallance; Alexandre C d'Audiffret; Stephanie J Frisbee; Lawrence E Tabone; Carl D Shrader; Jefferson C Frisbee; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

Review 3.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

4.  Chronic inhibition of epidermal growth factor receptor tyrosine kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2) augments vascular response to limb ischemia in type 2 diabetic mice.

Authors:  Soo-Kyoung Choi; Maria Galán; Megan Partyka; Mohamed Trebak; Souad Belmadani; Khalid Matrougui
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

Review 5.  Solid-state SPECT technology: fast and furious.

Authors:  Tali Sharir; Piotr J Slomka; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

6.  The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.

Authors:  Raúl R Rodrigues-Diez; Ana Belen Garcia-Redondo; Macarena Orejudo; Raquel Rodrigues-Diez; Ana Maria Briones; Enrique Bosch-Panadero; Gyorgy Kery; Janos Pato; Alberto Ortiz; Mercedes Salaices; Jesus Egido; Marta Ruiz-Ortega
Journal:  Antioxid Redox Signal       Date:  2015-01-01       Impact factor: 8.401

Review 7.  The prelude on novel receptor and ligand targets involved in the treatment of diabetes mellitus.

Authors:  Venu Gopal Jonnalagadda; Allam Venkata Sita Ram Raju; Srinivas Pittala; Afsar Shaik; Nilakash Annaji Selkar
Journal:  Adv Pharm Bull       Date:  2014-02-07

8.  Essential role for EGFR tyrosine kinase and ER stress in myocardial infarction in type 2 diabetes.

Authors:  Vishal Mali; Samuel Haddox; Corey Hornersmith; Khalid Matrougui; Souad Belmadani
Journal:  Pflugers Arch       Date:  2017-12-29       Impact factor: 3.657

9.  Diabetic cardiomyopathy: Role of epidermal growth factor receptor tyrosine kinase.

Authors:  Zheng Xu; Lu Cai
Journal:  J Mol Cell Cardiol       Date:  2015-04-10       Impact factor: 5.000

10.  The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction.

Authors:  Saghir Akhtar; Ibrahim Fadil Benter
Journal:  Bioimpacts       Date:  2013-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.